23 minutes ago
- copy link
Apart from India, the company will manufacture and supply the spray to many countries of Asia including Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Vietnam, Sri Lanka. -file photo
Nasal spray, which is useful for corona treatment, will soon be available in India. Indian company Glenmark Pharmaceuticals has tied up with Canadian company Sanotize Research and Development Corporation on Monday, which makes spray. Apart from India, the company will now work to supply spray to many countries of Asia including Singapore, Malaysia, Hong Kong, Taiwan, Nepal, Brunei, Cambodia, Laos, Myanmar, Vietnam, Sri Lanka.
The company’s managing director Glen Saldanha said that this would reduce the pressure of infection on the countries of Asia. He said that our company will take care that the spray can be supplied all over Asia as soon as possible.
How Nasal Spray Works
Phase-3 trials may be held in India
Israel and New Zealand have approved this spray for treatment. The company started production of the spray in Israel last month. Dr. Gili Regev, CEO and co-founder of Sanotize, had said that they are looking for partners in India and expect the spray to be approved as a medical device in India.
Sanotize wants to conduct Phase-3 trials with 4-5 thousand people. According to Regev, some part of Phase-3 trials may also take place in India. They are looking for funding for this. As soon as funding is received, the company will be able to go ahead and conduct trials in India.